Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?
Saved in:
Main Authors: | Jiayi Deng, Mingyi Yang, Qing Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2025-01-01
|
Series: | Cancer Biology & Medicine |
Online Access: | https://www.cancerbiomed.org/content/22/1/21 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
by: Jason C.S. Ho, et al.
Published: (2024-01-01) -
Treatment of oligometastatic breast cancer: The role of patient selection
by: Riccardo Ray Colciago, et al.
Published: (2025-02-01) -
Optimizing the Benefits of Mental Practice on Motor Acquisition and Consolidation with Moderate-Intensity Exercise
by: Rannaud Monany, Dylan, et al.
Published: (2023-07-01) -
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
by: Anna De Lucia, et al.
Published: (2025-02-01) -
AMPK: An energy sensor for non-small cell lung cancer progression and treatment
by: Zhi-Ting Zhong, et al.
Published: (2025-02-01)